TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)

Oncogenic pathways underlying in the development of myelodysplastic syndromes (MDS) remain poorly characterized, but mutations of the ten-eleven translocation 2 (TET2) gene are frequently observed. In the present work, we evaluated the prognostic impact of TET2 mutations in MDS. Frameshift, nonsense...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Blood Ročník 114; číslo 15; s. 3285
Hlavní autori:	Kosmider, Olivier, Gelsi-Boyer, Véronique, Cheok, Meyling, Grabar, Sophie, Della-Valle, Véronique, Picard, Françoise, Viguié, Franck, Quesnel, Bruno, Beyne-Rauzy, Odile, Solary, Eric, Vey, Norbert, Hunault-Berger, Mathilde, Fenaux, Pierre, Mansat-De Mas, Véronique, Delabesse, Eric, Guardiola, Philippe, Lacombe, Catherine, Vainchenker, William, Preudhomme, Claude, Dreyfus, François, Bernard, Olivier A, Birnbaum, Daniel, Fontenay, Michaëla
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 08.10.2009
Predmet:	Aged Aged, 80 and over Disease-Free Survival DNA-Binding Proteins - genetics DNA-Binding Proteins - metabolism Female Follow-Up Studies Genetic Markers Humans Male Middle Aged Mutation Myelodysplastic Syndromes - genetics Myelodysplastic Syndromes - mortality Predictive Value of Tests Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins - metabolism Risk Factors Survival Rate
ISSN:	1528-0020, 1528-0020
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!